Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 4/20 | 0.72 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.72 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.72 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.72 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.72 |
| ▸ | HDAC5 | Q9UQL6 | 3/20 | 0.72 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.72 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.72 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.72 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.72 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.72 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.72 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.72 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.72 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.72 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.64 |
| ▸ | NPC1 | O15118 | 1/20 | 0.64 |
| ▸ | CASP3 | P42574 | 1/20 | 0.64 |
| ▸ | RAB9A | P51151 | 1/20 | 0.64 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL30882401 | 0.98 | HDAC1 (0.69) | HDAC1HDAC3HDAC2HDAC8HDAC6 | |
| Water SCHEMBL28210512 | 0.98 | HDAC1 (0.69) | HDAC1HDAC3HDAC2HDAC8HDAC6 | |
| Hydrochloric Acid SCHEMBL23062929 | 0.98 | HDAC1 (0.69) | HDAC1HDAC3HDAC2HDAC8HDAC6 | |
| Hydrochloric Acid SCHEMBL30882658 | 0.98 | HDAC1 (0.69) | HDAC1HDAC3HDAC2HDAC8HDAC6 | |
| SCHEMBL5020709 | 0.96 | HDAC1 (0.67) | HDAC1HDAC3HDAC2HDAC8HDAC6 | |
| SCHEMBL1285919 | 0.93 | MAPT (0.70) | HDAC1HDAC3HDAC2HDAC8HDAC6 | |
| SCHEMBL1327206 | 0.91 | MAPT (0.74) | HDAC1HDAC3HDAC2HDAC8HDAC6 | |
| SCHEMBL5981360 | 0.91 | MAPT (0.74) | HDAC1HDAC3HDAC2HDAC8HDAC6 | |
| SCHEMBL1285525 | 0.91 | MAPT (0.74) | HDAC1HDAC3HDAC2HDAC8HDAC6 | |
| SCHEMBL21359026 | 0.91 | MAPT (0.74) | HDAC1HDAC3HDAC2HDAC8HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3224 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12383624-B2 | Cargo delivery system and composition comprising the same | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) | 2025-08-12 | — | — | US | claimed |
| US-12208071-B2 | Glucagon receptor antagonists | LIGAND PHARMACEUTICALS INCORPORATED (US) | 2025-01-28 | — | — | US | claimed |
| US-12186329-B2 | Compositions and methods related to cholic acid 7-sulfate as a treatment for diabetes | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2025-01-07 | — | — | US | claimed |
| US-12180188-B2 | Antifibrotic compounds and related methods | FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2024-12-31 | — | — | US | claimed |
| US-20240316048-A1 | Prevention of Pancreatic Cell Degeneration | MELIOR PHARMACEUTICALS I, INC. | 2024-09-26 | — | — | US | claimed |
| US-12070461-B2 | Methods and formulations for modulating Lyn kinase activity and treating related disorders | MELIOR PHARMACEUTICALS I, INC. (US) | 2024-08-27 | — | — | US | claimed |
| US-20230263821-A1 | Treatment Of Increased Lipid Levels With Sterol Regulatory Element Binding Transcription Factor 1 (SREBF1) Inhibitors | UNIVERSITY OF MARYLAND, BALTIMORE | 2023-08-24 | — | — | US | claimed |
| EP-4153177-A1 | ANTIFIBROTIC COMPOUNDS AND RELATED METHODS | Florida State University Research Foundation, Inc. (US) | 2023-03-29 | — | — | EP | claimed |
| US-20230090542-A1 | Antifibrotic Compounds And Related Methods | THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES | 2023-03-23 | — | — | US | claimed |
| US-11548874-B2 | Antifibrotic compounds and related methods | FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2023-01-10 | — | — | US | claimed |
| WO-1999033855-A1 | 11β-HALOGEN-7α-SUBSTITUTED ESTRATRIENES, METHOD FOR PRODUCING PHARMACEUTICAL PREPARATIONS CONTAINING SAID 11β-HALOGEN-7α-SUBSTITUTED ESTRATRIENES AND USE OF THE SAME FOR PRODUCING MEDICAMENTS | SCHERING AKTIENGESELLSCHAFT (DE) | 1999-07-08 | — | — | WO | claimed |
| US-5859037-A | MIXTURE SYNERGISTIC FOR THE TREATMENT OF NON-INSULIN DEPENDENT DIABETES MELLITUS IN HUMANS, WHICH ALSO IMPROVES GLYCEMIC CONTROL | WARNER-LAMBERT COMPANY (US) | 1999-01-12 | — | — | US | claimed |
| EP-0610744-B1 | Sulfonamide aminomethylene derivatives as immunosuppressants | BAYER AG (US) | 1998-11-04 | — | — | EP | claimed |
| WO-1998036755-A1 | SULFONYLUREA-GLITAZONE SYNERGISTIC COMBINATIONS FOR DIABETES | WARNER LAMBERT COMPANY (US) | 1998-08-27 | — | — | WO | claimed |
| US-5686469-A | ANTIINFLAMMATORY AGENTS | MILES INC. (US) | 1997-11-11 | — | — | US | claimed |
| CN-1112117-A | Imidazole-containing inhibitors of farnesyl protein transferase | BRISTOL MYERS SQUIBB CO (US) | 1995-11-22 | — | — | CN | claimed |
| EP-0298758-B1 | Hydroquinonylphenyl butyric acid amide derivative | SUNTORY LTD (JP) | 1995-06-28 | — | — | EP | claimed |
| EP-0610745-A2 | Novel aminomethylene derivatives as immunosuppressants | Bayer Corporation (US) | 1994-08-17 | — | — | EP | claimed |
| EP-0316820-B1 | THIAZOLE COMPOUNDS, PROCESSES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1992-01-22 | — | — | EP | claimed |
| US-4921887-A | ANTIALLERGENS | FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) | 1990-05-01 | — | — | US | claimed |